Transcriptional activation by the thyroid hormone receptor through ligand-dependent receptor recruitment and chromatin remodelling

Nature Communications

Volumn 6, Issue , 2015, Pages

  Grøntved, Lars ^a,b   Waterfall, Joshua J ^a   Kim, Dong Wook ^a   Baek, Songjoon ^a   Sung, Myong Hee ^a   Zhao, Li ^a   Won Park, Jeong ^a   Nielsen, Ronni ^b   Walker, Robert L ^a   Zhu, Yuelin J ^a   Meltzer, Paul S ^a   Hager, Gordon L ^a   Cheng, Sheue Yann ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYRIBONUCLEASE; LIGAND; THYROID HORMONE; THYROID HORMONE RECEPTOR; LIOTHYRONINE;

DNA; FOOTPRINT; GENE EXPRESSION; HORMONE; LIGAND; RODENT;

ANIMAL TISSUE; ARTICLE; BINDING SITE; CHROMATIN; CONTROLLED STUDY; DNA FOOTPRINTING; GENE ACTIVATION; GENE SEQUENCE; GENOME; LIVER; MOUSE; NONHUMAN; TRANSCRIPTION INITIATION; ANIMAL; BIOLOGICAL MODEL; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMATIN IMMUNOPRECIPITATION; DNA SEQUENCE; METABOLISM;

ANIMALS; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMATIN IMMUNOPRECIPITATION; LIGANDS; LIVER; MICE; MODELS, BIOLOGICAL; RECEPTORS, THYROID HORMONE; SEQUENCE ANALYSIS, DNA; TRANSCRIPTIONAL ACTIVATION; TRIIODOTHYRONINE;

EID: 84928788176     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms8048     Document Type: Article

References (61)

1. Cheng, S. Y., Leonard, J. L. & Davis, P. J. Molecular aspects of thyroid hormone actions. Endocr. Rev. 31, 139-170 (2010).
2. Baumann, C. T., Maruvada, P., Hager, G. L. & Yen, P. M. Nuclear cytoplasmic shuttling by thyroid hormone receptors. multiple protein interactions are required for nuclear retention. J. Biol. Chem. 276, 11237-11245 (2001).
3. Wong, J., Shi, Y. B. & Wolffe, A. P. A role for nucleosome assembly in both silencing and activation of the Xenopus TR beta A gene by the thyroid hormone receptor. Genes Dev. 9, 2696-2711 (1995).
4. Tong, G. X., Jeyakumar, M., Tanen, M. R. & Bagchi, M. K. Transcriptional silencing by unliganded thyroid hormone receptor beta requires a soluble corepressor that interacts with the ligand-binding domain of the receptor. Mol. Cell Biol. 16, 1909-1920 (1996).
5. Chen, J. D., Umesono, K. & Evans, R. M. SMRT isoforms mediate repression and anti-repression of nuclear receptor heterodimers. Proc. Natl Acad. Sci. USA 93, 7567-7571 (1996).
6. Horlein, A. J. et al. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377, 397-404 (1995).
7. Lin, B. C., Hong, S. H., Krig, S., Yoh, S. M. & Privalsky, M. L. A conformational switch in nuclear hormone receptors is involved in coupling hormone binding to corepressor release. Mol. Cell Biol. 17, 6131-6138 (1997).
8. Perissi, V. et al. Molecular determinants of nuclear receptor-corepressor interaction. Genes Dev. 13, 3198-3208 (1999).
9. Chen, H. et al. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell 90, 569-580 (1997).
10. Fondell, J. D., Ge, H. & Roeder, R. G. Ligand induction of a transcriptionally active thyroid hormone receptor coactivator complex. Proc. Natl Acad. Sci. USA 93, 8329-8333 (1996).
11. Xu, L., Glass, C. K. & Rosenfeld, M. G. Coactivator and corepressor complexes in nuclear receptor function. Curr. Opin. Genet. Dev. 9, 140-147 (1999).
12. Mullur, R., Liu, Y. Y. & Brent, G. A. Thyroid hormone regulation of metabolism. Physiol. Rev. 94, 355-382 (2014).
13. Brent, G. A. Mechanisms of thyroid hormone action. J. Clin. Invest. 122, 3035-3043 (2012).
14. Astapova, I. & Hollenberg, A. N. The in vivo role of nuclear receptor corepressors in thyroid hormone action. Biochim. Biophys. Acta 1830, 3876-3881 (2013).
15. Perissi, V., Jepsen, K., Glass, C. K. & Rosenfeld, M. G. Deconstructing repression: evolving models of co-repressor action. Nat. Rev. Genet. 11, 109-123 (2010).
16. Mottis, A., Mouchiroud, L. & Auwerx, J. Emerging roles of the corepressors NCoR1 and SMRT in homeostasis. Genes Dev. 27, 819-835 (2013).
17. Grontved, L. et al. C/EBP maintains chromatin accessibility in liver and facilitates glucocorticoid receptor recruitment to steroid response elements. EMBO J. 32, 1568-1583 (2013).
18. John, S. et al. Chromatin accessibility pre-determines glucocorticoid receptor binding patterns. Nat. Genet. 43, 264-268 (2011).
19. Miranda, T. B. et al. Reprogramming the chromatin landscape: interplay of the estrogen and glucocorticoid receptors at the genomic level. Cancer Res. 73, 5130-5139 (2013).
20. Voss, T. C. & Hager, G. L. Dynamic regulation of transcriptional states by chromatin and transcription factors. Nat. Rev. Genet. 15, 69-81 (2014).
21. Grontved, L. et al. Rapid genome-scale mapping of chromatin accessibility in tissue. Epigenetics Chromatin 5, 10 (2012).
22. Ramadoss, P. et al. Novel mechanism of positive versus negative regulation by thyroid hormone receptor beta1 (TRbeta1) identified by genome-wide profiling of binding sites in mouse liver. J. Biol. Chem. 289, 1313-1328 (2014).
23. Ayers, S. et al. Genome-wide binding patterns of thyroid hormone receptor Beta. PLoS ONE 9, e81186 (2014).
24. Chatonnet, F., Guyot, R., Benoit, G. & Flamant, F. Genome-wide analysis of thyroid hormone receptors shared and specific functions in neural cells. Proc. Natl Acad. Sci. USA 110, E766-E775 (2013).
25. He, H. H. et al. Differential DNase I hypersensitivity reveals factor-dependent chromatin dynamics. Genome Res. 22, 1015-1025 (2012).
26. Berrodin, T. J., Marks, M. S., Ozato, K., Linney, E. & Lazar, M. A. Heterodimerization among thyroid hormone receptor, retinoic acid receptor, retinoid X receptor, chicken ovalbumin upstream promoter transcription factor, and an endogenous liver protein. Mol. Endocrinol. 6, 1468-1478 (1992).
27. Oppenheimer, J. H. & Schwartz, H. L. Molecular basis of thyroid hormonedependent brain development. Endocr. Rev. 18, 462-475 (1997).
28. Wrange, O., Carlstedt-Duke, J. & Gustafsson, J. A. Purification of the glucocorticoid receptor from rat liver cytosol. J. Biol. Chem. 254, 9284-9290 (1979).
29. Yen, P. M. et al. Effects of ligand and thyroid hormone receptor isoforms on hepatic gene expression profiles of thyroid hormone receptor knockout mice. EMBO Rep. 4, 581-587 (2003).
30. Astapova, I. et al. The nuclear corepressor, NCoR, regulates thyroid hormone action in vivo. Proc. Natl Acad. Sci. USA 105, 19544-19549 (2008).
31. You, S. H., Liao, X., Weiss, R. E. & Lazar, M. A. The interaction between nuclear receptor corepressor and histone deacetylase 3 regulates both positive and negative thyroid hormone action in vivo. Mol. Endocrinol. 24, 1359-1367 (2010).
32. He, H. H. et al. Refined DNase-seq protocol and data analysis reveals intrinsic bias in transcription factor footprint identification. Nat. Methods 11, 73-78 (2014).
33. Sung, M. H., Guertin, M. J., Baek, S. & Hager, G. L. DNase footprint signatures are dictated by factor dynamics and DNA sequence. Mol. Cell 56, 275-285 (2014).
34. Faure, A. J. et al. Cohesin regulates tissue-specific expression by stabilizing highly occupied cis-regulatory modules. Genome Res. 22, 2163-2175 (2012).
35. Siersbaek, R. et al. Molecular architecture of transcription factor hotspots in early adipogenesis. Cell Rep. 7, 1434-1442 (2014).
36. Boyle, A. P. et al. High-resolution genome-wide in vivo footprinting of diverse transcription factors in human cells. Genome Res. 21, 456-464 (2011).
37. Perlman, A. J., Stanley, F. & Samuels, H. H. Thyroid hormone nuclear receptor. Evidence for multimeric organization in chromatin. J. Biol. Chem. 257, 930-938 (1982).
38. Jump, D. B. & Oppenheimer, J. H. Thyroid hormone receptor-containing fragment released from chromatin by deoxyribonuclease I and micrococcal nuclease. Science 209, 811-813 (1980).
39. Liu, Y., Xia, X., Fondell, J. D. & Yen, P. M. Thyroid hormone-regulated target genes have distinct patterns of coactivator recruitment and histone acetylation. Mol. Endocrinol. 20, 483-490 (2006).
40. Voss, T. C. et al. Dynamic exchange at regulatory elements during chromatin remodelling underlies assisted loading mechanism. Cell 146, 544-554 (2011).
41. Maruvada, P., Baumann, C. T., Hager, G. L. & Yen, P. M. Dynamic shuttling and intranuclear mobility of nuclear hormone receptors. J. Biol. Chem. 278, 12425-12432 (2003).
42. Tewari, A. K. et al. Chromatin accessibility reveals insights into androgen receptor activation and transcriptional specificity. Genome Biol. 13, R88 (2012).
43. Ballare, C. et al. Nucleosome-driven transcription factor binding and gene regulation. Mol. Cell 49, 67-79 (2013).
44. Force, W. R. & Spindler, S. R. 3, 5, 3'-L-triiodothyronine (thyroid hormone)- induced protein-DNA interactions in the thyroid hormone response elements and cell type-specific elements of the rat growth hormone gene revealed by in vivo dimethyl sulfate footprinting. J. Biol. Chem. 269, 9682-9686 (1994).
45. Kim, S. W., Ahn, I. M. & Larsen, P. R. In vivo genomic footprinting of thyroid hormone-responsive genes in pituitary tumor cell lines. Mol. Cell Biol. 16, 4465-4477 (1996).
46. Kumar, S., Saradhi, M., Chaturvedi, N. K. & Tyagi, R. K. Intracellular localization and nucleocytoplasmic trafficking of steroid receptors: an overview. Mol. Cell Endocrinol. 246, 147-156 (2006).
47. Gertz, J. et al. Distinct properties of cell-type-specific and shared transcription factor binding sites. Mol. Cell 52, 25-36 (2013).
48. Pihlajamaa, P. et al. Tissue-specific pioneer factors associate with androgen receptor cistromes and transcription programs. EMBO J. 33, 312-326 (2014).
49. Biddie, S. C. et al. Transcription factor AP1 potentiates chromatin accessibility and glucocorticoid receptor binding. Mol. Cell 43, 145-155 (2011).
50. Brewster, R. C. et al. The transcription factor titration effect dictates level of gene expression. Cell 156, 1312-1323 (2014).
51. Reddy, T. E., Gertz, J., Crawford, G. E., Garabedian, M. J. & Myers, R. M. The hypersensitive glucocorticoid response specifically regulates period 1 and expression of circadian genes. Mol. Cell Biol. 32, 3756-3767 (2012).
52. Hurtado, A., Holmes, K. A., Ross-Innes, C. S., Schmidt, D. & Carroll, J. S. FOXA1 is a key determinant of estrogen receptor function and endocrine response. Nat. Genet. 43, 27-33 (2011).
53. Du, P., Kibbe, W. A. & Lin, S. M. lumi: a pipeline for processing Illumina microarray. Bioinformatics 24, 1547-1548 (2008).
54. Smyth, G. K., Michaud, J. & Scott, H. S. Use of within-array replicate spots for assessing differential expression in microarray experiments. Bioinformatics 21, 2067-2075 (2005).
55. Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows- Wheeler transform. Bioinformatics 25, 1754-1760 (2009).
56. Li, H. et al. The sequence alignment/map format and SAMtools. Bioinformatics 25, 2078-2079 (2009).
57. Baek, S., Sung, M. H. & Hager, G. L. Quantitative analysis of genome-wide chromatin remodelling. Methods Mol. Biol. 833, 433-441 (2012).
58. Anders, S. & Huber, W. Differential expression analysis for sequence count data. Genome Biol. 11, R106 (2010).
59. Heinz, S. et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38, 576-589 (2010).
60. Saeed, A. I. et al. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 34, 374-378 (2003).
61. Lazarovici, A. et al. Probing DNA shape and methylation state on a genomic scale with DNase I. Proc. Natl Acad. Sci. USA 110, 6376-6381 (2013).